✦ LIBER ✦

P87 Adjuvant therapy of primary breast cancer with doxorubicin vs. pirarubicin in combination with cyclophosphamide and 5-fluorouracil (FAC vs. FPC)

✍ Scribed by Z. Budišic; P. Podolski; L. Markulin-Grgić; F. Šantek; E. Kosovel

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adjuvant Therapy of Breast Cancer with P

✍ Jun-Jie Li; Gen-Hong Di; Li-Chen Tang; Ke-Da Yu; Zhen Hu; Guang-Yu Liu; Jing-Son 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB

383 Comparative study: Pirarubicin vs do

✍ Z. Budišić; H. Predrijevac; P. Podolski; M. Gošev 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 291 KB

Quality of life and toxicity in breast c

✍ N. Hatam; N. Ahmadloo; A. Ahmad Kia Daliri; P. Bastani; M. Askarian 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 178 KB

Improvement in Disease-Free Survival wit

✍ Amy I. D'Orazio; Joyce O'Shaughnessy 📂 Article 📅 2002 🏛 CIG Media Group, LP. 🌐 English ⚖ 96 KB

PCN12 IMPACT OF ADJUVANT CHEMOTHERAPY WI

✍ H Miadi-Fargier; C Le Pen; MC Woronoff-Lemsi; JP Guastalla; X Pivot; H Roché; F 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

Doxorubicin and cyclophosphamide adjuvan

✍ Dino Amadori 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 346 KB